An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers

An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers

Non-small cell lung cancer (NSCLC) is the most prevalent and fatal lung cancer. The multiepitope vaccine is one of the immunotherapies successfully applied to treat NSCLC. We designed a multiepitope vaccine with MHC-I, MHC-II, CTL, and linear B cell epitopes of MAGE-A3, EGF, and MUC-1 oncoproteins e...

Full description

Bibliographic Details
Main Authors: Md Mijanur Rahman, Md Habib Ullah Masum, Asma Talukder, Rekha Akter
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Non-small cell lung cancer
Reverse vaccinology
Multiepitope vaccine
MAGE-A3
EGF
MUC-1
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914823000114

Internet

http://www.sciencedirect.com/science/article/pii/S2352914823000114

Similar Items